By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
Achillion Pharmaceuticals, Inc. (ACHN) Shows Potential For "Best-In-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422 12/22/2014 6:19:04 AM
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure 12/22/2014 6:18:24 AM
Why Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Are Keeping An Eye On Achillion Pharmaceuticals, Inc. (ACHN) 12/12/2014 6:15:51 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences 11/25/2014 2:04:04 PM
Achillion Pharmaceuticals, Inc. (ACHN) Reports 100% SVR12 In A Phase 2 Combination Study With ACH-3102 At The Liver Meeting 2014 (American Association for Study of Liver Diseases) 11/10/2014 7:22:23 AM
Achillion Pharmaceuticals, Inc. (ACHN) Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform At The 56th Annual Meeting Of The American Society of Hematology 11/6/2014 10:41:08 AM
Achillion Pharmaceuticals, Inc. (ACHN) Reports Third Quarter And Nine Month 2014 Financial Results 11/4/2014 8:20:42 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present Updated Clinical HCV Data On ACH-3102 And Preclinical Profile Of ACH-3422 At The American Association for Study of Liver Diseases Annual Meeting 10/8/2014 1:01:51 PM
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/27/2014 6:27:16 AM
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014 7:39:16 AM
12345678910...
//-->